Researchers from Peter Mac have discovered an innovative way to dampen severe inflammation, uncovering a potential new therapeutic approach for inflammatory and autoimmune conditions such as arthritis, psoriasis and liver disease, as well as some cancers.
A new approach to prostate cancer treatment increases the visibility of prostate cancer cells that have spread to bone for better recognition and killing by the immune system.
Due to COVID-19, Peter MacCallum Cancer Centre, the Royal Women’s Hospital, the Royal Melbourne Hospital and The Royal Children’s Hospital are postponing the go-live of the Parkville Electronic Medical Record (EMR).
Peter Mac’s Executive Director Cancer Research, Prof Ricky Johnstone, has announced the appointment of three new Associate Directors covering clinical, translational and health services and implementation science.
Results from a Peter Mac-led randomised controlled trial – the proPSMA Study - find that a new molecular imaging technique is more accurate than conventional medical imaging and recommends the scans be introduced into routine clinical practice.
Peter Mac is experiencing a high volume of calls so we're working with Cancer Council Australia’s Information and Support line to ensure we can best support our patients and families.
Infectious diseases clinician, Dr Olivia Smibert, is the first Peter Mac student ever awarded the Gustav Nossal Scholarship – NHMRC’s top PhD scholarship – to undertake studies into whether the gut microbiome can influence transplant success.